Sioril Uses, Dosage, Side Effects and more
Sioril was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
| Trade Name | Sioril |
| Generic | Oxyphenbutazone |
| Oxyphenbutazone Other Names | Oxifenbutazona, Oxiphenbutazone, Oxyphenbutazone, Oxyphenbutazonum |
| Type | Tablet |
| Formula | C19H20N2O3 |
| Weight | Average: 324.3737 Monoisotopic: 324.147392516 |
| Groups | Approved, Withdrawn |
| Therapeutic Class | |
| Manufacturer | Albert David Limited |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Sioril is a nonsteroidal anti-inflammatory drug (NSAID) no longer commonly used for the symptomatic relief of musculoskeletal pain.
Food Interaction
- Take with food. Food reduces irritation.
